JUMET, Belgium, June 9, 2022 /PRNewswire/ -- Exothera S.A., a leading CDMO that specializes in the development and manufacture of viral vectors for vaccines and gene therapies, has developed and is ...
Regulatory requirements stipulate that the production of any agents intended for use in human clinical trials must be performed under current Good Manufacturing Practices (cGMP). 1 Retroviral vector ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback